March 24, 2021

post-hospitalisation COVID-19 (PHOSP-COVID) study: a national consortium to understand and improve long-term health outcomes

The impact of COVID-19 on physical and mental health, functional status and employment following hospitalisation is poorly understood.

This briefing covered data released as a preprint from the first 1,000 patients in the PHOSP-COVID study into the longer term effects on health outcomes of hospitalisation with COVID-19. It profiles the most typical ‘post-COVID’ symptoms, together with the demographic and health data of those who are most likely to continue to have persistent symptoms months after discharge, and a possible biological marker that may underpin some of these findings.

Speakers included:

Prof Chris Brightling, Professor of Respiratory Medicine, University of Leicester

Dr Rachael Evans, NIHR Clinical Scientist, University of Leicester

Prof Louise Wain, GSK/British Lung Foundation Chair in Respiratory Research, University of Leicester

Prof John Geddes, Head of Department of Psychiatry at the University of Oxford and Director of the Oxford Health Biomedical Research Centre

Dr Nazir Lone, Senior Clinical Lecturer in Critical Care at the University of Edinburgh and Consultant in Critical Care at the Royal Infirmary of Edinburgh